Pharmacogenetics - A new treatment possibility;Farmakogenetik - En ny behandlingsmulighed

Ugeskrift for Laeger

Volumn 167, Issue 20, 2005, Pages 2141-

  Ainsworth, Mark A ^a   Nielsen, Ole Haagen ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

CELL PROLIFERATION; CHROMOSOME 22; DENMARK; EDITORIAL; HUMAN; MYELOID LEUKEMIA; NOMENCLATURE; PHARMACOGENETICS; PHARMACOGENOMICS; PHILADELPHIA 1 CHROMOSOME;

DRUG INDUSTRY; HUMANS; PHARMACOGENETICS; TECHNOLOGY, PHARMACEUTICAL;

EID: 20344408554     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. EMEA/CPMP Position Paper on Terminology in PharmacoGenetics. EMEA/CPMP/3070/01 http://www.emea.eu.int/pdfs/human/press/pp/307001en.pdf/febr. 2005.
2. Brøsen K. Klassisk farmakogenetik. Ugeskr Læger 2005;167:2143-6.
3. Ross JS, Schenkein DP, Pietrusko R et al. Targeted therapies for cancer 2004. Am J Clin Pathol 2004;122:598-609.
4. Von Mehren M. Targeted therapy with imatinib: hits and misses? J Clin Oncol 2005;23:1-3.
5. Lesko LJ, Woodcock J. Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective. Nat Rev Drug Discov 2004;3:763-9.